期刊文献+

Multi-modality imaging in transthyretin amyloid cardiomyopathy

Multi-modality imaging in transthyretin amyloid cardiomyopathy
下载PDF
导出
摘要 Transthyretin amyloid(TTR)cardiomyopathy is a disease of insidious onset,which is often accompanied by debilitating neurological and/or cardiac complications.The true prevalence is not fully known due to its elusive presentation,being often under-recognized and usually diagnosed only late in its natural history and in older patients.Because of this,effective treatment options are usually precluded by multiple comorbidities and frailty associated with such patients.Therefore,high clinical suspicion with earlier and better detection of this disease is needed.In this review,the novel applications of multimodality imaging in the diagnostic pathway of TTR cardiomyopathy are explored.These include the complimentary roles of transthoracic echocardiography,cardiac magnetic resonance,nuclear scintigraphy and positron emission tomography in quantifying cardiac dysfunction,diagnosis and risk stratification.Recent advances in novel therapeutic options for TTR have further enhanced the importance of a timely and accurate diagnosis of this disease. Transthyretin amyloid(TTR) cardiomyopathy is a disease of insidious onset,which is often accompanied by debilitating neurological and/or cardiac complications. The true prevalence is not fully known due to its elusive presentation, being often under-recognized and usually diagnosed only late in its natural history and in older patients. Because of this, effective treatment options are usually precluded by multiple comorbidities and frailty associated with such patients. Therefore, high clinical suspicion with earlier and better detection of this disease is needed. In this review, the novel applications of multimodality imaging in the diagnostic pathway of TTR cardiomyopathy are explored. These include the complimentary roles of transthoracic echocardiography, cardiac magnetic resonance, nuclear scintigraphy and positron emission tomography in quantifying cardiac dysfunction, diagnosis and risk stratification. Recent advances in novel therapeutic options for TTR have further enhanced the importance of a timely and accurate diagnosis of this disease.
出处 《World Journal of Cardiology》 CAS 2019年第11期266-276,共11页 世界心脏病学杂志(英文版)(电子版)
关键词 MULTIMODALITY IMAGING CARDIAC AMYLOIDOSIS TRANSTHYRETIN Echocardiography CARDIAC magnetic resonance Nuclear IMAGING Multimodality imaging Cardiac amyloidosis Transthyretin Echocardiography Cardiac magnetic resonance Nuclear imaging
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部